Funding Rounds
Memo Therapeutics Series C (2023, $27M)
Memo TherapeuticsAntibody discovery and human immune repertoire analysis platform.
Summary
Stage: Series C
Raised Amount: $27.65M
Raised Date: 2023-02-01
Stage: Series C
Raised Amount: $27.65M
Raised Date: 2023-02-01
